威高血净
(603014)
| 流通市值：14.15亿 | | | 总市值：150.18亿 |
| 流通股本：3936.73万 | | | 总股本：4.18亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 904,266,262.9 | 3,768,719,939.38 | 2,736,052,670.24 | 1,764,680,364.12 |
| 营业收入 | 904,266,262.9 | 3,768,719,939.38 | 2,736,052,670.24 | 1,764,680,364.12 |
| 二、营业总成本 | 769,818,692.7 | 3,241,747,704.43 | 2,345,783,937.85 | 1,517,719,836.84 |
| 营业成本 | 552,327,288.04 | 2,252,667,429.83 | 1,622,620,708.78 | 1,039,385,001.73 |
| 税金及附加 | 11,337,981.54 | 52,632,207.36 | 38,627,463.44 | 28,857,798.17 |
| 销售费用 | 110,255,044.96 | 622,464,077.09 | 446,047,832.47 | 292,882,038.34 |
| 管理费用 | 54,510,842.8 | 167,331,096.28 | 132,273,878.93 | 87,887,839.91 |
| 研发费用 | 37,543,498.33 | 143,860,502.75 | 105,705,786.32 | 70,178,671.88 |
| 财务费用 | 3,844,037.03 | 2,792,391.12 | 508,267.91 | -1,471,513.19 |
| 其中:利息费用 | 369,556.34 | 743,115.28 | 283,020.98 | 233,422.09 |
| 其中:利息收入 | 245,917.99 | 2,135,383.1 | 1,593,221.93 | 1,771,084.14 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,375,560.33 | 986,109.59 | 998,835.62 | 902,054.6 |
| 加:投资收益 | 15,220,850.02 | 31,028,152.2 | 33,720,777.75 | 20,167,729.45 |
| 资产处置收益 | -8,523.31 | 21,839.9 | 24,614.94 | 21,568.75 |
| 资产减值损失(新) | -8,914,537.56 | -5,699,923.67 | -7,772,260.54 | -6,256,028.51 |
| 信用减值损失(新) | -5,759,499.21 | 1,402,772.41 | -22,782,858.05 | -3,985,682.74 |
| 其他收益 | 4,332,750.04 | 27,272,791.28 | 17,076,905.61 | 9,840,937.96 |
| 四、营业利润 | 140,694,170.51 | 581,983,976.66 | 411,534,747.72 | 267,651,106.79 |
| 加:营业外收入 | 140,385.61 | 1,689,820.01 | 583,025.99 | 372,013.92 |
| 减:营业外支出 | 954,648.79 | 7,851,855.94 | 5,712,368.48 | 3,860,638.33 |
| 五、利润总额 | 139,879,907.33 | 575,821,940.73 | 406,405,405.23 | 264,162,482.38 |
| 减:所得税费用 | 21,577,233.62 | 93,510,930.42 | 65,627,345.88 | 43,925,131.51 |
| 六、净利润 | 118,302,673.71 | 482,311,010.31 | 340,778,059.35 | 220,237,350.87 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 118,302,673.71 | 482,311,010.31 | 340,778,059.35 | 220,237,350.87 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 118,304,254.26 | 482,296,672.53 | 340,778,059.35 | 220,237,350.87 |
| 少数股东损益 | -1,580.55 | 14,337.78 | - | - |
| 扣除非经常损益后的净利润 | 112,295,505.26 | 464,011,456.05 | 333,221,997.86 | 214,612,844.34 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.28 | 1.22 | 0.85 | 0.58 |
| (二)稀释每股收益 | 0.28 | 1.22 | 0.85 | 0.58 |
| 八、其他综合收益 | 245,179.79 | -134,366.87 | -59,253.35 | -154,455.08 |
| 归属于母公司股东的其他综合收益 | 245,179.79 | -134,366.87 | -59,253.35 | -154,455.08 |
| 九、综合收益总额 | 118,547,853.5 | 482,176,643.44 | 340,718,806 | 220,082,895.79 |
| 归属于母公司股东的综合收益总额 | 118,549,434.05 | 482,162,305.66 | 340,718,806 | 220,082,895.79 |
| 归属于少数股东的综合收益总额 | -1,580.55 | 14,337.78 | - | - |
| 公告日期 | 2026-04-30 | 2026-03-28 | 2025-10-31 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |